Abstract

If you work with children, you must have this book.

For more than two decades, Pediatric Injectable Drugs (The Teddy Bear Book), has served an important and continuing need for reliable evidence-based information specific to pediatric injectable drugs.

The tenth edition of this invaluable reference has grown to cover 238 drugs commonly used in the treatment of infants and children, including 20 new to this edition. The Teddy Bear Book covers neonates through adolescents, with age-specific dosing and administration guidelines throughout. With three new editors, who collectively bring 75 years of pediatric pharmacy practice experience to the book, the tenth edition is the most thorough and comprehensive reference yet.

As with previous editions, the structure of each of the drug monographs covers the following areas:

• Brand Names
• Medication Error Potential
• Contraindications and Warnings
• Infusion-Related Cautions
• Dosage (age specific)
• Dosage Adjustment in Organ Dysfunction
• Maximum Dosage
• Additives
• Suitable Diluents
• Maximum Concentrations
• Preparation and Delivery
• IV Push
• Intermittent Infusion
• Continuous Infusion
• Other Routes of Administration
• Comments

Also included is a comprehensive list of abbreviations and more than 4800 references. This is the only pediatric (neonates through adolescents) parenteral drug reference that covers limited fluid amounts, maximum doses, and limited intravenous sites—issues that pediatric practitioners often face in their patients.

When it comes to pediatric injectable drugs, valid safety and efficacy research can be hard to locate. This indispensable reference changes all that.

Stephanie J. Phelps, PharmD, BCPS, received her baccalaureate pharmacy degree from Samford University and a doctor of pharmacy from The University of Tennessee. She subsequently completed postdoctoral training in pediatrics at LeBonheur Children’s Medical Center and The University of Tennessee. Dr. Phelps is currently a Professor of Clinical Pharmacy and Pediatrics at The University of Tennessee Health Science Center (UTHSC) and Associate Dean of Academic Affairs for the College of Pharmacy. For over a decade, she served as Director, of Experiential Education of the college. She is an elected Fellow of American College of Clinical Pharmacy (ACCP) and the American Pharmacists Association (APhA) and is a Board Certified Pharmacotherapy Specialist.

Dr. Phelps has held elected offices in AACP and ASHP and has served on the Board of Directors of American Society of Parenteral and Enteral Nutrition (ASPEN) and the Pediatric Pharmacy Advocacy Group (PPAG). She is currently chair of the Pharmacy Academy of the National Academies of Practice. She is a past recipient of the APhA-Academy of Student Pharmacists Outstanding Chapter Advisor award, the 2009 Tennessee Society of Hospital Pharmacy’s Distinguished Service Award and was recently selected by PPAG as the 2011 Helms Award recipient for Excellence in Pediatric Pharmacy Practice. Dr. Phelps has received numerous teaching awards and was the first pharmacy faculty member elected to the UTHSC campus Academy of Distinguished Teachers.

During her career she has participated in the education of five post-doctoral fellows and over 50 pediatric pharmacy residents. She is editor of the The Teddy Bear Book: Pediatric Injectable Drugs and is editor-in-chief of the Journal of Pediatric Pharmacology and Therapeutics. She has published numerous manuscripts, book chapters, and reviews that focus on pediatric pharmacotherapy.

Tracy M. Hagemann, PharmD, FCCP, FPPAG, received her doctor o pharmacy degree from the University of Missouri-Kansas City School of Pharmacy in 1994. She completed a pharmacy practice residency at the Regional Medical Center in Memphis, Tennessee, followed by a pediatric specialty residency at the University of Oklahoma and Children’s Hospital at OU Medical Center in Oklahoma City. Dr. Hagemann is an Associate Professor at the University of Oklahoma College of Pharmacy and an Adjunct Associate Professor at the College of Medicine, Department of Pediatrics. Her focus of practice and research is in pediatric hematology and oncology

. She is an elected fellow of both the American College of Clinical Pharmacy and the Pediatric Pharmacy Advocacy Group. She is an active member of various national pharmacy organizations and has held elected offices in PPAG, as well as the Oklahoma Society of Health-Systems Pharmacists. Her teaching and research has resulted in the publication of over 40 peer-reviewed journal articles and over 50 scientific abstracts. Dr. Hagemann has published book chapters in pediatric sickle cell disease in addition to her co-editorship of Pediatric Injectable Drugs.

Kelley R. Lee, PharmD, BCPS, received her doctorate of pharmacy degree from The University of Tennessee Health Science Center. She completed a two-year residency in pediatric pharmacotherapy at Le Bonheur Children’s Hospital and The University of Tennessee Health Science Center. After residency training, Dr. Lee served as a Clinical Pharmacy Specialist and then the Clinical Pharmacy Manager at Le Bonheur Children’s Hospital and part-time Professor of Clinical Pharmacy at the University of Tennessee Health Science Center. She has recently shifted focus to infectious diseases and is currently a Clinical Pharmacy Specialist in Antimicrobial Stewardship at Le Bonheur Children’s Hospital. Her practice and research interests have primarily been the appropriate use of medications in pediatric patients, particularly with the use of antibiotics. She has published numerous manuscripts, abstracts, and letters-to-the-editor on this subject.

A Jill Thompson, PharmD, BCPS, earned her doctor of pharmacy degree from the University of Tennessee Health Science Center in 2001, and completed PGY1 and PGY2 residencies in Pediatric Pharmacy Practice at Le Bonheur Children’s Medical Center in Memphis, Tennessee, from 2001 to 2003. Dr. Thompson is the Coordinator of Pediatric Clinical Pharmacy Services and is a Clinical Specialist in Pediatric Critical Care in the Department of Pharmacy Services, Medical University of South Carolina, Charleston, South Carolina. She also serves as an Adjunct Assistant Professor in the Department of Clinical Pharmacy and Outcomes Sciences at the South Carolina College of Pharmacy, MUSC Campus. Dr. Thompson participates in clinical research regarding pediatric critical care and works closely with the pharmacy residency programs at MUSC. She is recognized as a Board Certified Pharmacotherapy Specialist and is a member of the American College of Clinical Pharmacy, Pediatric Pharmacy Advocacy Group, and the Society of Critical Care Medicine. Prior to becoming a co-editor of Pediatric Injectable Drugs, she served as manuscript editor for the Journal of Pediatric Pharmacology and Therapeutics for seven years and is now a member of the editorial board.